Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1324
| Despition | Insulin Receptor Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1528 | Human RCAN3 Protein (AC1528) | 2 µg | inquiry |
| ACPP-1330 | PAX2 Blocking Peptide (AC1330) | 250 µg | inquiry |
| ACPP-1819 | Human TRH Protein (AC1819) | 100 mg | inquiry |
| ACPP-1405 | Human Ciliary Neurotrophic Factor (Active) Protein (AC1405) | 100 µg | inquiry |
| ACPP-1501 | Human STX2 Protein (AC1501) | 2 µg | inquiry |
| ACPP-1056 | Recombinant Human CX3CR1 Protein (Fc Tag) (AC1056) | 50 µg | inquiry |
| ACPP-1037 | Recombinant Human Robo1 Protein (Fc Tag) (AC1037) | 50 µg | inquiry |
| ACPP-1587 | Human TMED10 Protein (AC1587) | 2 µg | inquiry |
| ACPP-1017 | Recombinant Human FGF19 Protein (AC1017) | 50 µg | inquiry |
| ACPP-1143 | Recombinant Human Adenosine Receptor A2a Protein (Fc Tag) (AC1143) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.